将基化干扰素-α 添加到核胺类比物中,可以改善慢性乙型肝炎患者的HBsAg清除率,而这种患者患有较低水平的病毒性病
Lilin Wang1, Junfeng Lu1, Dan Liu1
1The First Department of Liver Disease Center, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Frontiers in medicine
|September 8, 2025
概括
结合治疗与核胺类同类 (NAs) 加上基化干扰素-α (pegIFN-α) 在慢性乙型肝炎 (CHB) 患者中改善了HBsAg清除. 这种方法可以提高治疗效率超出NA单一治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性乙型肝炎 (CHB) 中的低水平病毒病 (LLV) 与肝纤维化进展和肝细胞癌风险有关.
- 核胺类比物 (NA) 是标准的CHB治疗,但实现完全的病毒抑制和HBsAg清除仍然具有挑战性.
研究的目的:
- 为了比较NA疗法的疗效与与NA和 pegylated 干扰素-alfa (pegIFN-α) 结合疗法的疗效,在因特卡维尔 (ETV) 治疗的患有LLV的CHB患者中.
- 评估对乙型肝炎表面抗原 (HBsAg) 水平和完整病毒学反应 (CVR) 的影响.
主要方法:
- 回顾性队列研究包括127名接受ETV治疗的CHB患者LLV.
- 患者被分为两个组:NA组 (切换为tenofovir 胺酸) 和NA+IFN组 (添加pegIFN-α).
- 在48周内,各组之间的HBV标志物和CVR率的比较.
主要成果:
- 与NA组相比,NA+IFN组在24周的HBsAg水平下降显著更大,并且在48周的HBsAg清除率更高.
- 具体来说,在48周,NA+IFN组的HBsAg清除率为8.9%,而NA组的清除率为0% (P=0.017).
- 48周的CVR率在两组之间是可比的 (66.7%在NA+IFN和68.4%在NA,P=0.836).
结论:
- 在接受ETV治疗的CHB患者中,添加NA疗法中的pegIFN-α显著提高了HBsAg清除.
- 联合治疗可能在降低HBsAg水平方面具有优势,HBsAg水平是CHB进展的关键标志物.
- 虽然CVR率相似,但改善的HBsAg动力学表明组合治疗的潜在长期益处.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.6K
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
13.9K
相关概念视频
Viruses with RNA Genomes
840
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
840
Retrovirus Life Cycles
49.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.3K
